Literature DB >> 23109751

Implantation of left ventricular assist device complicated by undiagnosed thrombophilia.

Ondrej Szarszoi1, Jiri Maly, Daniel Turek, Marian Urban, Ivo Skalsky, Hynek Riha, Jana Maluskova, Jan Pirk, Ivan Netuka.   

Abstract

A patient with dilated cardiomyopathy and no history of thromboembolic events received a surgically implanted axial-flow left ventricular assist device. After implantation, transesophageal echocardiography revealed a giant thrombus on the lateral and anterior aspects of the left ventricle. The inflow cannula inserted through the apex of the left ventricle was not obstructed, and the device generated satisfactory blood flow. Laboratory screening for thrombophilia showed protein S deficiency, heterozygous factor V Leiden mutation, and heterozygous MTHFR C667T mutation. During the entire duration of circulatory support, no significant suction events were detected, and the patient was listed for heart transplantation. Ventricular assist device implantation can unmask previously undiagnosed thrombophilia; therefore, it should be necessary to identify thrombophilic patients before cardiac support implantation.

Entities:  

Keywords:  Anticoagulants/therapeutic use; blood coagulation disorders/complications; factor V Leiden; factor V/genetics; left ventricular assist device; perioperative care; postoperative complications; thrombophilia/genetics; thrombus/etiology/prevention & control

Mesh:

Substances:

Year:  2012        PMID: 23109751      PMCID: PMC3461681     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  7 in total

Review 1.  Risk factors in venous thromboembolism.

Authors:  I Martinelli
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

2.  The response to activated protein C after cardiopulmonary bypass: impact of factor V leiden.

Authors:  Brian S Donahue
Journal:  Anesth Analg       Date:  2004-12       Impact factor: 5.108

3.  Early occlusion of coronary by-pass associated with the presence of factor V Leiden and the prothrombin 20210A allele: case report.

Authors:  M L Varela; Y P Adamczuk; M E Martinuzzo; R R Forastiero; F R Klein; A S Rossi; L O Carreras
Journal:  Blood Coagul Fibrinolysis       Date:  1999-10       Impact factor: 1.276

4.  Antiphospholipid syndrome in cardiac surgery-an underestimated coagulation disorder?

Authors:  Parwis Massoudy; Sürreya M Cetin; Matthias Thielmann; P Kienbaum; Jarowit A Piotrowski; Günter Marggraf; Christof Specker; Heinz Jakob
Journal:  Eur J Cardiothorac Surg       Date:  2005-02-24       Impact factor: 4.191

5.  Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting.

Authors:  E Moor; A Silveira; F van't Hooft; P Tornvall; M Blombäck; B Wiman; L Rydén; A Hamsten
Journal:  Thromb Haemost       Date:  1998-08       Impact factor: 5.249

6.  Thrombophilia in cardiac surgery-patients with symptomatic factor V Leiden.

Authors:  Parwis Massoudy; Matthias Thielmann; Hannes Müller-Beissenhirtz; Klaus Görlinger; Wulf Dietrich; Stefan Herget-Rosenthal; Heinz Jakob
Journal:  J Card Surg       Date:  2009 Jul-Aug       Impact factor: 1.620

7.  Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation.

Authors:  Andrew J Boyle; Stuart D Russell; Jeffrey J Teuteberg; Mark S Slaughter; Nader Moazami; Francis D Pagani; O Howard Frazier; Gerald Heatley; David J Farrar; Ranjit John
Journal:  J Heart Lung Transplant       Date:  2009-09       Impact factor: 10.247

  7 in total
  1 in total

Review 1.  Medical Management of Pump-Related Thrombosis in Patients with Continuous-Flow Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis.

Authors:  Geetanjali Dang; Narendranath Epperla; Vijayadershan Muppidi; Natasha Sahr; Amy Pan; Pippa Simpson; Lisa Baumann Kreuziger
Journal:  ASAIO J       Date:  2017 Jul/Aug       Impact factor: 2.872

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.